A novel in vitro model of trophoblast-mediated decidual blood vessel remodeling.
In vivo the extravillous trophoblasts (EVTs) penetrate the decidua and the first third of the myometrium to remodel the uterine spiral arteries and achieve the high-flow, low-resistance circulation characteristic of the intervillous space of the term placenta. Much of our understanding of these processes comes from histologic analysis of placental bed biopsies, a limited tissue source and one that can provide only a snapshot of a dynamic process. To better characterize these cellular interactions, we have developed an in vitro co-culture system in which first trimester villous explants are cultured at low oxygen tension in contact with 2-mm(2) sections of decidua parietalis from the same patient. Hematoxylin eosin counterstaining of paraffin sections shows that EVT columns form at the tips of the placental villi and adhere and penetrate the decidual surface. The decidual blood vessels in the path of the EVT show morphologic disruption. Immunohistochemical analysis of the co-cultures using both an endothelial specific anti-CD31 and an anti-smooth muscle actin antibody show a disruption of the integrity of the vessel lining together with a complete loss of organized smooth muscle actin surrounding the blood vessels. In contrast control decidua samples in the absence of placental villi exhibit blood vessels with a complete endothelial lining and an organized muscular sheath. Using both an anti-cytokeratin-7 and anti-Cdx-2 antibody specific to trophoblasts, we show that these changes coincide with invasion of the vessels by endovascular trophoblasts and penetration of the decidua by interstitial EVTs. No EVTs were found in the control decidua. Thus we conclude that this in vitro model mimics the physiologic change observed in vivo during trophoblast invasion into maternal decidual tissues, and as such it may provide useful information concerning the interactions between EVTs and decidual cells and vessels during early gestation.
Dunk
Caroline
C
Departments of Physiology and Fetal and Maternal Health, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Petkovic
Ljiljana
L
Baczyk
Dora
D
Rossant
Janet
J
Winterhager
Elke
E
Lye
Stephen
S
D000199:Actins / Q000032:analysis; D000328:Adult; D001158:Arteries / Q000033:anatomy & histology / Q000737:chemistry / Q000378:metabolism; D015415:Biomarkers / Q000032:analysis; D000071616:CDX2 Transcription Factor; D002478:Cells, Cultured; D002824:Chorionic Villi / Q000033:anatomy & histology / Q000737:chemistry / Q000502:physiology; D018920:Coculture Techniques; D003656:Decidua / Q000098:blood supply / Q000166:cytology / Q000502:physiology*; D004730:Endothelium, Vascular / Q000737:chemistry / Q000166:cytology / Q000502:physiology; D005260:Female; D018398:Homeodomain Proteins / Q000032:analysis; D006801:Humans; D007124:Immunoenzyme Techniques; D053552:Keratin-7; D007633:Keratins / Q000032:analysis; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000032:analysis; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D015534:Trans-Activators; D014327:Trophoblasts / Q000737:chemistry / Q000166:cytology / Q000502:physiology*
D000199:Actins; D015415:Biomarkers; D000071616:CDX2 Transcription Factor; D018398:Homeodomain Proteins; C507497:KRT7 protein, human; D053552:Keratin-7; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D015534:Trans-Activators; D007633:Keratins